Its depletion induces significant defects in erythroid differentiation of CD34+ hematopoietic stem cells (HSC), which is one of the features of the 5q- syndrome and, thus, potentially links RBM22 to the pathogenesis of this MDS entity [40]. This evidence concerns the gene RBM22 and myelodysplastic syndrome.